Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
VistaPath Biosystems
AddedFeb 15, 2024
UpdatedJun 18, 2026
VistaPath Biosystems

VistaPath Biosystems

Series A

VistaPath Biosystems: An AI-powered pathology lab automating tissue inspection and measurement.

HQ
Cambridge, MA, US
Founded
2017
Overview
Compare
Fundraising
Employees
Website

VistaPath Biosystems, founded with the mission to revolutionize pathology labs through automation, focuses on enhancing patient safety and efficiency in tissue inspection. The company offers an AI-powered tissue grossing platform that automates the processes of inspecting, inking, and measuring tissues, aiming to digitize and streamline pathology workflows. Their market focus includes anatomic pathology labs seeking to improve accuracy and reduce manual labor through advanced technological solutions.

Notable affiliations include collaborations with PathAI and Gestalt Diagnostics, which aim to validate and accelerate the adoption of VistaPath's automated tissue grossing platform. These partnerships highlight the company's commitment to integrating AI into pathology practices. Key achievements include launching innovative collaborations and receiving industry recognition for their contributions to pathology digitization. VistaPath Biosystems has significantly impacted the field by enhancing diagnostic precision and operational efficiency in pathology labs.

VistaPath Biosystems - Similar Companies

Instapath Inc. logo

Instapath Inc.

instapathbio.com

PathAI logo

PathAI

HistoWiz logo

HistoWiz

histowiz.com

OmniVis logo

OmniVis

Applikate Technologies logo

Applikate Technologies

4D Path logo

4D Path

4dpath.com

Valar Labs logo

Valar Labs

valarlabs.com

Viz.ai logo

Viz.ai

viz.ai

PathogenDx logo

PathogenDx

pathogendx.com

PathologyWatch logo

PathologyWatch

Gopath Laboratories logo

Gopath Laboratories

PathGroup logo

PathGroup

Proscia logo

Proscia

proscia.com

BioticsAI logo

BioticsAI

biotics.ai

Crosscope logo

Crosscope

crosscope.com

VistaPath Biosystems - Quick Facts

Who are VistaPath Biosystems' competitors?

Companies similar to VistaPath Biosystems include Instapath Inc., PathAI, HistoWiz and OmniVis.

When was VistaPath Biosystems founded?

VistaPath Biosystems was founded in 2017.

Where is VistaPath Biosystems' headquarters located?

VistaPath Biosystems' headquarters is located in Cambridge, MA, US.

When was VistaPath Biosystems' last funding round?

VistaPath Biosystems' most recent funding round was for $4.4M (USD) in July 2023.

How much has VistaPath Biosystems raised to-date?

As of Jul 7, 2023, VistaPath Biosystems has raised a total of $16.3M (USD).

How many employees does VistaPath Biosystems have?

VistaPath Biosystems has 17 employees as of Feb 5, 2024.

VistaPath Biosystems - Classification

Industry
  • Hardware
Ownership
  • Private
  • Venture Capital
Technology
  • AI
  • Automation
Geographic Exposure
  • Americas
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Medical Devices
Tags
  • AI Operations
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 5 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7372Prepackaged Software